Regulations and Reimbursement of Software as a Medical Device in Europe- Part1

With the advancement of technologies leading to a shift in how healthcare is administered and delivered, software has become an essential component of the development of medical devices. Particularly “Stand alone” software or “Software as a Medical Device (SaMD)” has seen fast growth recently as there is no hardware involved, fewer constraints as well as the use of fast feedback loops for improvement. Part 1 of this publication series from IQVIA – an associate member of AdvaMed® – explores SaMD definition, its challenges and the ways the regulatory bodies try to address them, as well as the expected development of regulations related to Artificial Intelligence (AI) and Machine Learning (ML) in SaMD.
Related Reading
Resource / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs / Workforce Advancement
The Economic Impact of the Medical Technology Industry 2024
October 27, 2025
Explore AdvaMed’s 2024 Economic Impact Report, developed by Frost & Sullivan, highlighting medtech’s vital contributions to the U.S. economy
News / Global & Trade / Supply Chain / Tariffs
AdvaMed Responds to Commerce Department Section 232 National Security Investigation, Seeks Policies to Strengthen U.S. Position as Global Medtech Leader
October 17, 2025
WASHINGTON—AdvaMed, the medtech association, today submitted formal comments responding to the U.S. Department of Commerce investigation into whether the U.S.’s current level of medtech imports has national security implications. The comments outlined medtech as an American success story and the United States as the global leader in innovating and making the highest quality medtech for the United States and world, an export powerhouse, and much less reliant on medtech imports than sometimes perceived.
Event / Compliance / Global & Trade / Legal
Supreme Court Term in Review: Implications for the Medical Technology Industry
																								November 18, 2025 
11:00 AM – 12:00 PM
																					
Supreme Court Term in Review: Implications for the Medical Technology Industry
News / Code of Ethics / Digital Health / Legal
AdvaMed Leads with Integrity: Updated Code of Ethics Now Available
October 6, 2025
WASHINGTON, D.C. – AdvaMed, the Medtech Association, today announced that its board of directors has unanimously approved revisions to the AdvaMed Code of Ethics on Interactions with Health Care Professionals.
Event / Digital Health / research & policy papers
Engineering the Future of MedTech with Insight-Driven Platforms
																								November 12, 2025 
12:30 PM – 1:30 PM
																					
Discover how Medtronic, a global leader in medical technology, partnered with GlobalLogic and AWS to help engineer the Future of MedTech with Insight-Driven Platforms
News / Digital Health / Regulatory Affairs
AdvaMed Releases Technical Performance and Safety Bulletin on “Remote Device Operations: Common Challenges and Mitigation Strategies”
October 2, 2025
WASHINGTON, D.C. – AdvaMed, the Medtech Association, recently published a technical performance and safety bulletin titled, “Remote Device Operations: Common Challenges and Mitigation Strategies” to help health care providers, device manufacturers, and IT teams navigate the complex landscape of remotely managing medical devices.
News / Global & Trade / Government & Legislative Affairs / Health Access / Supply Chain / Tariffs
AdvaMed Statement on Commerce Department Section 232 National Security Investigation
September 25, 2025
WASHINGTON—AdvaMed, the MedTech Association, released the following statement from President and CEO Scott Whitaker on the Administration’s announcement of its investigation under Section 232 of the Trade Expansion Act into whether the U.S.’s current level of medtech imports has national security implications:
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Thanks U.S. House Energy and Commerce Health Subcommittee for Highlighting the Need for Medicare Coverage of Breakthrough Medtech
September 18, 2025
WASHINGTON—AdvaMed, the medtech association, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft of breakthrough coverage legislation at a hearing, “Examining Policies to Enhance Seniors’ Access to Breakthrough Medical Technologies.”